atepeq/tico19 huggingface dataset:
Intriguingly, HCoV-NL63 also binds to ACE2 but with a different part of S.
Si xiiso leh, HCoV-NL63 ayaa sidoo kale ku dhaga ACE2 balse la jiranka qaybta kale ee S.
There exist many other HCoV receptors, such as aminopeptidase N for HCoV-229E, and 9-O-acetylated sialic acid for HCoV-OC43.
Waxaa jira dareemayaal HCoV oo kale, sida aminopeptidase N oo loogu talagalay HCoV-229E, iyo 9-O-acetylated sialic acid oo loogu talagalay HCoV-OC43.
They might also account for successful adaptation of these CoVs in humans after interspecies transmission from their animal hosts.
Waxaa lagaa yaabaa in ay sababaan la qabsashada CoV yada bina adamka si guul ah kadib isu gudbinta noolaha dhexdiisa ah ee ka imaanaya xayawaanka xanuun sidaha ah.
In addition to cellular receptors, the outcome of interspecies transmission of HCoVs is also governed by other host dependency and restriction factors.
Dareemayaashaa unug ahaaneed waxaa dheer, natiijada usii gudbinta HCoV yada ee noolaha-isku midka dhexdiisa waxaa sidoo kale maamula ku tiirsanaan la'aanta xanuun-side kale iyo asbaabaha xayiraada.
The divergence of these host proteins between humans and natural reservoir hosts of HCoVs such as bats, dromedary camels and rodents might constitute a barrier to interspecies transmission.
Kala duwanaanshaha borotiinadan xanuun-sidaha ee u dhexeeya bina aadamka iyo kaydiyayaasha xanuun-sidaha HCoVs ee dabiiciga ah sida fiidmeerta, geela halka kuruska leh iyo jiirka ayaa laga yaabaa inay ka qaybqaataan ka hortaga isu gudbinta noolaha isku midka ah.
HCoVs have to usurp host dependency factors and subvert host restriction factors for a successful interspecies transmission.
HCoV yada way in ay kala wareegan asbaabaha ku tiirsanaan la'aanta xanuun-sidaha oo ay hoos udhigaan asbaabaha xayiraada xanuun-sidaha si ay si guul ah isugu gubiyaan noolaha isku midka ah.
In this regard, molecular determinants in this important area of virus-host interaction remain to be identified and characterized.
Marka la eego, qeexayaasha molecule ahaaneed ee gudaha goobtan muhiimka ah ee isdhexgalka xanuun-sidaha fayraska waa in la cayimaa lana astaameeya.
An unbiased genome-wide screening of host dependency and restriction factors for SARS-CoV-2 using the state-of-the-art technology of CRISPR might be fruitful.
Baaritaanka hidde side balaadhan oo aan wasakhaysaneyn ee ku tiirsanaanta xanuun-sidaha iyo asbaabaha xayiraada ee SARS-CoV-2 ayadoo la istcimaalayo heerka xirfada tiknoolaji ee CRISPR ayaa laga yaaba in ay miro dhasho.
Emergence of novel HCoVs: back to ground zero
Soo if-bixitaanka HCoV yada cusub: lagu celinayo meeshuu kasoo bilawday.
The diversity of bat CoVs provides ample opportunities for the emergence of novel HCoVs.
Kala duwanaanshaha CoV yada fiidmeerta wuxuu siinayaa fursado ku filan soo ifbixitaanka HCoV yo cusub.
In this sense, bat CoVs serve as the gene pool of HCoVs.
Dareenkan, CoVs fiidmeerta waxay u adeegtaa sida hidde sidayaasha dhan HCoVs.
In addition, rapid mutation and genetic recombination also drive HCoV evolution and serve as two important steps in this process.
Intaas waxaa dheer, isbadalka koriin ee xawliga ah iyo dib isku dhafka hida sidaha sidoo kale waxay keenayaan qiimaynta HCoV waxayna u adeegaan laba talaabo oo muhiim hawshan.
For example, the acquisition or loss of novel protein-coding genes has the potential to drastically modify viral phenotypes.
Tusaale ahaan, helitaanka ama waayitaanka hida sidaha borotiinka qeexa wuxuu suurtagalnayaa inuu sii weyn u cusboonaysiiyaan isku mid ahaanshaha hida sidaha fayraska
Among SARS-CoV accessory proteins, ORF8 has been thought to be important in adaptation to humans, as SARS-CoV-related bat viruses were isolated but found to encode divergent ORF8 proteins.
Waxaa ka mid ah borotiinada dheeraadka ah ee SARS-CoV, ORF8 ayaa loo maleeyaa in uu muhiim u yahay la qabshada bina'adamka, sida SARS-CoV ka la xariira fayrasyada fiidmeerta loo karantiilay balse la ogaaday in ay soo saaraan borotiinada ORF8 oo kala duwan.
A 29-nucleotide deletion characteristic of SARS-CoVs has been found in strains isolated at the beginning of the human epidemic.
Tirtirida sifooyinka 29-nucleotide ee SARS-CoV yada ayaa laga helay kooxo la karantiilay bilawgii cudurka safmareenka ah ee bina'adamka ku dhaca.
This deletion splits ORF8 into ORF8a and ORF8b and is thought to be an adaptive mutation that promotes the switch of hosts.
Waayitaanka unugyada ORF8 ee ORF8a iyo ORF8b waxaana loo malaynayaa in ay tahay la qabsashada isbadallada koriin kaas oo hormarinaysa badalidda xanuun-sidayaasha.
Besides, SARS-CoV has a possible recombination history with lineages of alpha- and gamma-CoVs, where a large number of smaller recombinant regions were identified in the RNA-dependent RNA polymerase.
Kasokow, SARS-CoV wuxuu leeyehay suurtagalnimada tariikh iskudhafka hida side ahaaneed ee alpha iyo beta-CoV, halka tira badan oo aagag yaryar ee isku dhafka hida sidaha lagu arkay RNA ga ku tiirsan RNA polymerase.
Recombination locations were also identified in the nsp9, most of nsp10, and parts of nsp14.
Goobaha dib-isugu dhafka hida sidaha ayaa sidoo kale lagu sheegay nsp9, inta badan nsp10, iyo qaybo nsp14 ah.
Likewise, it has been shown that the epidemic MERS-CoV experienced recombination events between different lineages, which occurred in dromedary camels in Saudi Arabia.
Sidoo kale, waxaa la arkay in cudurka safmareenka ee MERS-CoV lagu arkay dhacdooyinka dib u habaynta hida sidaha ee faracyo kala duwan, kuwaas oo ku dhacay geela halka kurus leh ee gudaha Sacuudi Carabiya.
Besides SARS-CoV and MERS-CoV, recombination events have also been observed in other HCoVs, in which the HCoVs recombine with other animal CoVs in their non-structural genes.
Kasokow SARS-CoV iyo MERS-CoV, dib isku dhafka dhacdooyinka ayaa sido kale lagu arkay HCoV yada kale, halkaas oo HCoVs isku dhafaan hida sidayaasha aan qaab-dhismeed lahayn ee CoVs xayawaanada kale.
It should also be cautioned that artificial selection can contribute to unintended changes in viral genomes, most likely resulting from relieving viruses from selection pressures exerted, such as by the host immune system.
Waa in sidoo kale laga taxadaraa in xulashada aadanuhu ay ka qayb qaadan karto isbadallo aan loo qasdin oo ku dhaca hida-sidaha fayraska, inta badan kuwa sababaya ka bogsashada fayrasyada ee cadaadiska xulasho la saaray, sida habka difaaca jirka ee xanuun-sidaha.
An example of these effects is the loss of a full-length ORF4 in the HCoV-229E prototype strain, owing to a two-nucleotide deletion.
Tusaalaha saamaynta waa waayida dheerarka caadiga ah ee noocyada isku midka ah ee ORF4 ee HCoV-229E, kuwaas oo leh waayida laba-nucleotude.
While intact ORF4 could be observed in bat and camel viruses related to HCoV-229E, the alpaca alpha-CoV displays a single nucleotide insertion, resulting in a frameshift.
Halka dhaawac la'aanta ORF4 lagu arki karo fiidmeerta iyo fayrasyada geela la xariira HCoV-229E, alpaca alpha-CoV uu muujinayo halka galitaan oo nucleotide ah, kaaso ka dhalanaya isbaladda koriinaadka ee hida-sidaha.
Last but not least, the evolution of novel HCoVs is also driven by the selection pressure in their reservoir hosts.
Ugu dambeyntiina ugu yar, qiimaynta HCoVs cusub ayaa sidoo kale laga keenay shay'yaasha badala hida-sidaha kaydiyaasha xanuunka ee xanuun-sidaha.
Asymptomatic or only mild symptoms were detected when bats were infected with CoVs, indicating the mutual adaptation between CoVs and bats.
Muujin la'aanta calaamado ama kaliya calaamado fudud ayaa lagu arkay marka fiidmeeraha qaadeen caabuqa CoV yada, taas oo tusinaysa isla qabsashada labada dhinac ee u dhexeeya CoV yada iyo fiid-meeraha.
It appeared that bats are well adapted to CoVs anatomically and physiologically.
Waxay u muuqatay in fiidmeerta ay si wanaagsan ula qabsadeen CoV yada qaab jir ahaaneed iyo qaabka shaqayn ahaaneed ba.
For example, defects in the activation of pro-inflammatory response in bats efficiently reduce the pathology triggered by CoVs.
Tusaale ahaan, ciladaha keenaya jawaab celinta waxyaalaha bararka keena ee fiidmeerta ayaa si waxtar leh hoos ugu dhigta jeermisyada ay kiciyaan CoV yada.
Besides, the natural killer cell activity in bats is suppressed due to upregulation of inhibitory natural killer cell receptor NKG2/CD94 and low expression level of major histocompatibility complex class I molecules.
Waxaa dheer, dilaaga dabiiciga ah ee hawlaha unugyada fiidmeerta ayaa lacadaadiyay sababtoo ah kordhinta kicinta xanibidda dilayaasha dabiiciga ah ee dareemaha unuga NKG2/CD94 iyo heerka qeexitaan ee hooseeya ee wada jirka molecule ka Fasalka I.
Moreover, the high level of reactive oxygen species (ROS) generated from high metabolic activity of bats could both suppress CoV replication and affects proofreading by exoribonuclease, thus providing the selection pressure for the generation of virus strains highly pathogenic when introduced into a new host.
Kasokow, heerka sare ee kicinta oksijiinka noolaha (ROS) kaas oo ka dhashay hawlaha dheef-shiidka kiimikada ee fiidmeeraha ayaa labaduba cadaadiya taranka CoV iyo saamaynta dib u akhrinta exoribonuclease, taas oo siinaysa xulashada cadaadiska ee soo sarista noocyada fayraska jeermiska badan leh marka la galiyo xanuun-qaade cusub.
More pathogenic CoV strains might also evolve by recombination, leading to the acquisition of novel proteins or protein features for host adaptation.
Noocyo badan oo ah jeermisyada sababa CoV ayaa laga yaabaa in ay si tartiib ah u koraan ayagoo dib isugu dhafmaya, taas oo keenaysa helitaanka borotiinada cusub ama borotiino leh astaamaha la qabsashada xanuun-sidaha.
Thus, it is not by chance that three novel HCoVs have emerged in the past two decades.
Sidaas awgeed, si bakhtiyaa nasiib ah ma aha in saddexda HCovs ee cusub ee hada soo shaac-bexeen inta lagu jiray labaatankii sanno ee lasoo dhaafay.
CoVs are non-pathogenic or cause mild symptoms in their reservoir hosts such as bats and camels.
CoV yada waa kuwa aan jeermis lahayn ama aan u sababin calaamado fudud kaydiyayaashoda xanuun-side sida fiid-meeraha iyo geela.
They replicate robustly without eliciting a strong host immune response.
Waxay u tarmaan si xoog ah iyaga oo aan mancinayn jawaab celinta adag ee difaaca jirka xanuun-sidaha.
Herein lie the secrets of why asymptomatic carriers are seen and what causes the severe cases in human infection.
Halkan waxaa ka jira sirta sababta loo arko dadka xanuun-sidayaasha ee aan wax calaamad ah muujinin iyo waxa sababa kiisaska ba'an ee caabuqa bina aadamka.
The severe symptoms are mainly due to the hyperactivation of immune response and the cytokine storm wherein the stronger the immune response, the more severe the lung damage.
Calaamadaha ba'an ayaa ah kuwa badanaa sabab u ah hawl-galinta aadka ee ka jawaab celinta difaaca iyo dhibaatada cytokine halka jawaab celinta difaaca jirka ee adag, ay u badantahay dhaawac ba'an oo wadna la dhaawaco.
In contrast, in asymptomatic carriers, the immune response has been de-coupled from CoV replication.
Taa badalkeed, xanuun-sidayaaha aan calaamadaha muujinin, jawaab celinta difaaca jirka waxaa kala gooyay taranka CoV.
The same strategy of delinking the immune response might have beneficial effects in anti-SARS-CoV-2 therapy.
Istaraajiyada lamidka ah ee xiriirka loogu jarayo jawaab celinta difaaca jirka ayaa laga yaaba in ay u leedehey saamayn faaiido leh daaweynta la dagaalanka SARS-CoV-2
The interferon response is particularly strong in bats.
Jawaab celinta interferon ayaa si gaar ah ugu xoogan fiidmeeraha.
Thus, administration of type I interferon at least in the early phase of SARS-CoV-2 infection in humans should be beneficial.
Sidaas awgeed, qaadashada nooca I interferon ugu yaraan marxalada hore ee caabuqa SARS-CoV-2 ee bina aadamka ayaa ah mid faaido leh.
In addition, NLRP3 inflammasome activation in bats is defective.
Intaas waxaa dheer, NLRP3 ga inflammasome ee fiidmeeraha waa mid cillad leh.
By this reasoning, inhibition of NLRP3 inflammasome with MCC950 might be useful in the treatment of COVID-19.
Sababayntan, xanibaada NLRP3 inflammasome ee leh MCC950 ayaa waxtar u leh daaweynta COVID-19.
The emergence of SARS-CoV-2 follows the general theme by which SARS-CoV and MERS-CoV arose.
Soo ifbaxa SARS-CoV-2 wuxuu dabasocdaa mawduuca guud kaas oo SARS-CoV iyo MERS-CoV ay kasoo baxeen.
Whereas a bat beta-CoV sharing 95% nucleotide homology with SARS-CoV has been found, there also exists a bat-CoV sharing 96% nucleotide homology with SARS-CoV-2.
Halka fiidmeerta beta-CoV ay la wadaagayso 95% isu eekaansho nucleotide SARS-CoV ayaa la ogaaday, sidoo kale waxaa jira CoV fiidmaar kaas oo la wadaagaya 96% isu ekaansho nucleotide SARS-CoV-2.
Whereas civets and other animals in the markets have been found to harbour viruses identical to SARS-CoV, immediate intermediate hosts for SARS-CoV-2 have not been identified.
Halka bisadaha baadiyaha iyo xoolaha kale ee suuqa ku jira la ogaaday inay kaydiyaan fayruusyada lamidka ah SARS-CoV, xanuun sidaha dhexe ee ugu dhaw ee SARS-CoV ayaan la aqoonsanin.
Pangolin beta-CoVs strikingly homologous to SARS-CoV-2 have been found, indicating that pangolins might serve as one of intermediate hosts or pangolin beta-CoVs could contribute gene fragments to the final version of SARS-CoV-2.
Beta-CoVs pangolin ee sida wayn ugu eeg SARS-CoV-2 ayaa la ogaaday, iyagoo muujinaya in pangolins ka ay noqon karaan mid kamid ah xanuun sidayaasha dhexdhexaadka ah mise beta-CoVs pangolin ayaa siin kara qayb hidde ah nooca u dambeeya ee SARS-CoV-2.
Although questions remain, there is no evidence that SARS-CoV-2 is man-made either deliberately or accidentally.
Inkastoo su'aaluhu ay taaganyihiin, ma jirto cadeyn in SARS-CoV-2 ay tahay mid bini aadam sameeyay si ula kac ah ama si kama'a ah.
CoVs have returned to the limelight due to the recent outbreak of SARS-CoV-2.
CoV yada waxay u laabteen iftiinka cad sababtoo ah dilaacitaanka dhaw ee SARS-CoV-2.
The study of CoVs in bats and other animals has drastically changed our perception of the importance of zoonotic origins and animal reservoirs of HCoVs in human transmission.
Daraasada CoV yada ee fiidmaaraha iyo xoolaha kale ayaa si wayn u badashay fikradeena ah muhiimada asalka xanuunka xoolaha ee u gudba bini'aadanka iyo deegaanka xoolaha ee HCoV yada ee u gudbinta bini'aadanka.
Pervasive evidence has shown that SARS-CoV, MERS-CoV and SARS-CoV-2 have a bat origin and are transmitted to humans via intermediate hosts.
Cadeynta balaaran ayaa muujisay in SARS-CoV, MERS-CoV iyo SARS-CoV-2 ay leeyihiin asal fiidmeer loona gudbiyo bini aadamka iyadoo loo marayo xanuun side dhexdhexaad ah.
Given that SARS-CoV infection originates from the contact between humans and civets in the markets, closing wet markets and killing civets therein could have effectively ended the SARS epidemic.
Hadii caabuqa SARS-CoV uu kasoo farcamay is taabashada bini aadamka iyo bahalka loo yaqaan civets ee suuqa taala, xiritaanka suuqyada qoyan iyo dilitaanka civets markaas wuxuu si wax ku ool ah uu dhamayn lahaa safmareenka SARS.
By the same reasoning, pangolins should be removed from wet markets to prevent zoonotic transmission, in view of the discovery of multiple lineages of pangolin beta-CoVs closely related to SARS-CoV-2.
Sababaynta lamidka ah, pangolin yada waa in laga saaraa suuqyada qoyan si looga hortago gudbinta xanuunka xoolaha ee u gudba bini'aadanka, marka la eego ogaanshaha dhawr noole ee pangolin beta-CoV yada ayaa si dhaw ula xiriira SARS-CoV-2.
However, whether and how SARS-CoV-2 is transmitted to humans through pangolins and other mammals remain to be clarified in future investigations.
Si kasta ha ahaatee, hadii iyo sida SARS-CoV-2 loogu gudbiyo bini aadamka isagoo u maraya pangolin iyo naaslayaasha kale ayaa ah mid in lagu cadeeya ah baaritaanada mustaqbalka.
On the other hand, MERS-CoV has existed in dromedary camels for a long time.
Dhinaca kale, MERS-CoV ayaa ku jiray geela halka kurus leh mudo dheer.
These camels serve as an important tool for transportation as well as a main source of meat, milk, leather and wool products for the local people.
Geelan waxaa waaye qalab muhiim ah oo gaadiid ah iyo sidoo kale isha ugu wayn ee laga hello hilib, caano, maqaar iyo alaabta dhogorta ee ka hellaan dadka maxalliga ah.
They are widely distributed across the Middle East and Africa.
Waxaa si balaaran loogu qaybiyay daafaha Bariga dhexe iyo Afrika.
It is therefore impossible to sacrifice all camels for the control of MERS, as what was done in wild animal markets in China to prevent the spreading of SARS-CoV and SARS-CoV-2.
Sidaas darteed waa suurtagal in la huro dhamaan geela si loo xakameeyo MERS, sida wixii lagu sameeyay xoolaha duur joogta ee Shiinaha si looga hor tago faafitaanka SARS-CoV iyo SARS-CoV-2.
To stop the recurrent outbreaks of MERS, a comprehensive approach should be taken to develop effective vaccines against MERS-CoV for camels, in combination with other infection control measures.
Si loo joojiyo soo noqnoqoshada dilaacyada MERS, hab dhamaystiran waa in la qaado si loo sameeyo talaalo shaqaynaya ee ku aadan MERS-CoV ee geela, iyadoo ay la socoto talaabooyin kale oo xakamaynta caabuqa.
As we are not able to eliminate these viruses, new genotypes might emerge to cause outbreaks.
Maadaama aynaan awoodin inaan cirib tirno fayraasyadan, genotypes cusub ayaa soo ifbixi kara si ay u sababaan dilaacyo.
A variety of zoonotic CoVs are circulating in the wild.
CoV yada xanuunka xoolaha ee u gudba bini'aadanka oo kala duwan ayaa ku wareegaya hawdka.
Particularly, bat CoVs with zoonotic potential are so diverse.
Gaar ahaan, CoV yada fiidmaarta ee leh suurtagalnimada xanuunka xoolaha ee u gudba bini'aadanka ayaa saaid ukala duwan.
There are plenty of opportunities that these zoonotic CoVs evolve and recombine, resulting in the emergence of new CoVs that are more transmissible and/or deadly in humans in future.
Waxaa jira fursado badan oo CoV yada xanuunka xooluhu uu bini'aadanka qaadsiiyo ay ku hormarayaan ayna dib isugu imaanayaan, iyagoo sababaya inay soo ifbaxaan CoV yo cusub kuwaas oo si badan loogu gudbin karo iyo/ama aad u laynaya bini'aadanka mustaqbalka.
The culture of eating wild animals in some places of China should be abandoned to reduce unnecessary contact between humans and animals.
Dhaqanka cunista xoolaha duurjoogta ee meelaha qaar Shiinaha waa in layska daayaa si loo yareeyo xiriir aan loo baahnayn oo u dhaxeeya bini'aadanka iyo xoolaha.
With the ordeals of SARS, MERS and COVID-19, a better preparedness and response plan should be in place.
Dhibaatooyinka SARS, MERS iyo COVID-19, diyaar garaw wanaagsan iyo qorshe falcelin waa in meel la dhigaa.
In fact, many viruses have existed in the planet for a very long time.
Xaqiiq ahaan, fayruusyo badan ayaa ka jiray dhulka waqti aad u dheer.
They stay in their own natural reservoirs until there is a chance for spillover.
Waxay joogaan kaydkooda dabiiciga ah ilaa ka timaado fursad uu meel kale ku faafo.
Although bats have many features that favours the spreading of viruses, the chance for humans to be in contact with bats and other wildlife species can be minimized if people are educated to stay away from them.
Inkastoo fiidmeeruhu ay leeyihiin astaamo badan oo ka caawinaya fidinta fayraasyada, fursada bini aadamku uu kula xiriiri karo fiidmeerta iyo noolayaasha duurjoogta ayaa la yarayn karaa hadii dadka wax la baro si ay uga dheeraadaan.
Continuous surveillance in mammals is necessary for better understanding of the ecology of CoVs and their natural hosts, which will prove useful in preventing animal-to-human transmission and future outbreaks.
Korjoogtayn socota ee naaslayda ayaa u haboon fahan fiican ee degaanka CoV yada iyo xanuun sidayaashooda dabiiciga ah, kuwaas oo cadaynaya waxtarkooda ka hortaga ka gudbitaanka xoolaha u gudbaya bini'aadanka iyo dilaacista mustaqbalka.
To conclude, the most effective way to prevent viral zoonosis is for humans to stay away from the ecological niches of the natural reservoirs of the zoonotic viruses.
Si loo soo gabagabeeyo, habka ugu waxtarka leh ee lagaga hortagi karo fayruusyada xanuunada xoolaha ee u gudba bini'aadanka ayaa loogu talagalay bini'aadanka inuu ka fogaado deegaaan nololeedka kaydka dabiiciga ee fayruusyada xanuunada xoolaha ee u gudba bini'aadanka.
Several pieces in the puzzle of the zoonotic origin of SARS-CoV-2 are still missing.
Qaybo dhawr ah ee xujada asalka xanuunka xoolaha ee u gudba bini'aadanka ee SARS-CoV-2 ayaa wali maqan.
First, if bats transmit an ancestral virus of SARS-CoV-2 to pangolins, it will be of interest to see under what circumstances bats and pangolins could share the same ecological niche.
Tan koobaad, hadii fiidmeeruhu ay gudbiyaan fayras hore ee SARS-CoV-2 ee ku aadan pangolin yada, waxay noqon doontaa mid danayn leh in la arko duruufaha keenay fiidmeeraha iyo qarindiyaasha inay wadaagaan deegaan nololeed isku mid ah.
Second, if bats play a more direct role in human transmission, how humans get into contact with bats should be determined.
Tan labaad, hadii fiidmeeruhu ay door toos ah oo badan ka ciyaaraan u gudbinta bini aadamka, sida aadanuhu uu ku taabto fiidmeerta waa in la ogaadaa.
Third, if a third mammal acts as the true intermediate host, how it interacts with the different species including humans, bats and pangolins has to be clarified.
Tan saddexaad, hadii naasle saddexaad uu noqdo xanuun sidaha dhex dhexaad ee runta ah, sida ay u dhex gasho noolayaasha kala duwan ee ay kamid yihiin bin aadamka, fiidmeeraha iyo pangolin yada waa in la cadeeyo.
Finally, since many mammals including domestic animals might be susceptible to SARS-CoV-2, both surveillance and experimental infection should be conducted.
Ugu dambayn, maadaama naaslay badan oo ay ku jiraan xoolaha la dhaqdo ay qaadi karaan SARS-CoV-2, labadaba waardiyayn iyo caabuq tijaabo ah waa in la sameeyo.
Should it be a bat, a pangolin or another mammal, it is expected that SARS-CoV-2 or its parental viruses that are almost identical will be identified in its natural hosts in future.
Haday ahaato fiidmeer, pangolin mise naasle kale, waxaa la rajaynayaa in SARS-CoV-2 misane fayraasyada ay kasoo farcameen kuwaas oo inta badan isu eeg ayaa la ogaan doonaa iyadoo ku jirta xanuun sidaheeda dabiiciga ah mustqabalka.
Continued investigations in this area will elucidate the evolutionary pathway of SARS-CoV-2 in animals, with important implications in the prevention and control of COVID-19 in humans.
Baaritaano sii socda ee goobtan ayaa cadeyn doona jidka isbadelka ee SARS-CoV-2 ee xoolaha, iyadoo leh natiijooyin muhiim ah ee ka hortaga iyo xakamaynta COVID-19 ee bini'aadanka.
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020
Qiimaynta hordhaca ah ee balaarnida xaaladaha caafimaad ee hooseeya ee lagasoo xushay bukaanada qaba xanuunka Coronavirus 2019- Maraykanka, Febraayo 12- Maarso 28. 202.
On March 11, 2020, the World Health Organization declared Coronavirus Disease 2019 (COVID-19) a pandemic.
Maarso 11, 2020, Hay'ada Caafimaadka aduunka waxay cadaysay in xanuunka Coronavirus 2019 (COVID-19) uu yahay xanuun caalami ah.
As of March 28, 2020, a total of 571,678 confirmed COVID-19 cases and 26,494 deaths have been reported worldwide.
Ilaa iyo Maarso 28, 2020, wadar ah 571,678 kiisas COVID-19 oo la xaqiijiyay iyo 26,494 dhimasho ayaa caalamka guud ahaan laga soo sheegay.
Reports from China and Italy suggest that risk factors for severe disease include older age and the presence of at least one of several underlying health conditions.
Warbixinnada ka imanaya Shiinaha iyo Talyaaniga ayaa soo jeedinaya in qodobada khatarta ee xanuunada ba'an ay ku jiraan da'da wayn, iyo inuu ku jiro ugu yaraan hal xaalad caafimaad oo hoosaysa.
U.S. older adults, including those aged ≥65 years and particularly those aged ≥85 years, also appear to be at higher risk for severe COVID-19–associated outcomes; however, data describing underlying health conditions among U.S. COVID-19 patients have not yet been reported.
Dadka waawayn ee Maraykanka, oo ay ku jiraan kuwa jira wax ka wayn ama lamid ah 65 sano iyo gaar ahaan kuwa jira wax ka wayn ama lamid ah 85 sano, ayaa sidoo kale u muuqda inay khatar sare ugu jiraan natiijooyin ba'an oo la xiriira COVID-19, si kastaba ha ahaatee, xogta qeexaysa xaaladaha caafimaad ee hooseeya ee bukaanada COVID-19 ee Maraykanka ayaan wali lasoo sheegin.
As of March 28, 2020, U.S. states and territories have reported 122,653 U.S. COVID-19 cases to CDC, including 7,162 (5.8%) for whom data on underlying health conditions and other known risk factors for severe outcomes from respiratory infections were reported.
Ilaa iyo Maarso 28, 2020, gobollada Maraykanka iyo dhulalkiisa waxay u soo sheegeen CDC Maraykanka 122,653 kiisas oo COVID-19 ah, oo ay ku iraan 7,162(5.8%) kuwaas oo xogta xaaladaha caafimaad ee hoose iyo qodobada kale ee khatarta la yaqaan ee natiiooyinka ba'an ee caabuqa neefmareenka laga soo sheegay.
Among these 7,162 cases, 2,692 (37.6%) patients had one or more underlying health condition or risk factor, and 4,470 (62.4%) had none of these conditions reported.
7,162 kiisas waxaa kamid ah, 2,692(37.6%) bukaano waxay lahaayeen hal ama ka badan oo xaalad caafimaad oo hoosaysa mise qodob khatar ah, iyo 4,470(62.4%) maysan lahayn xaaladahan lasoo sheegay.
The percentage of COVID-19 patients with at least one underlying health condition or risk factor was higher among those requiring intensive care unit (ICU) admission (358 of 457, 78%) and those requiring hospitalization without ICU admission (732 of 1,037, 71%) than that among those who were not hospitalized (1,388 of 5,143, 27%).
Boqollayda bukaanada COVID-19 ee leh ugu yaraan hal xaalad oo hoose misane khatar caabuq ayaa aad u sareeyay marka loo eego dadka u baahnaa gaynta qeybta daryeelka degdegga (ICU) (358 kamid ah 457, 78%) iyo kuwa u baahan isbitaal in la seexayo iyadoon la geyn ICU (732 kamid ah 1,037, 71%) marka loo eego kuwa aan isbitaal la seexinin (1,388 kamid ah 5,143, 27%)
The most commonly reported conditions were diabetes mellitus, chronic lung disease, and cardiovascular disease.
Xaaladaha ugu badan ee lasoo sheegay waxay ahaayeen sonkorawga mellitus, sanbabo xanuun daba dheeraaday, iyo wadno xanuun.
These preliminary findings suggest that in the United States, persons with underlying health conditions or other recognized risk factors for severe outcomes from respiratory infections appear to be at a higher risk for severe disease from COVID-19 than are persons without these conditions.
Natiiooyinka hordhaca ah waxay soo jeedinayaanin Maraykanka, dadka leh xaalad caadimaad oo hoosaysa misane khatar caabuq oo kale oo la yaqaano ee natiijooyinka ba'an ee ka yimid caabuqyada neefmareenka waxay u muuqdaan inay khatar wayn ugu jiraan xanuun ba'an oo kaga yimaada COVID-19 marka loo eego dadka aan xaaladahan qabin.
Data from laboratory-confirmed COVID-19 cases reported to CDC from 50 states, four U.S. territories and affiliated islands, the District of Columbia, and New York City with February 12–March 28, 2020 onset dates were analyzed.
Xogta ka timid kiisaska shaybaarka lagu xaqiijiyay ee COVID-19 ee loo sheegay CDC ee ka timid 50 gobol, afar goob oo Maraykan ah iyo jasiiradaha ay wadaagaan, Degmada Columbia, iyo magaalada New York ee Febraayo 12-Maarso 28, 2020 taariikhaha markaas ayaa la falanqaeeyay.
Cases among persons repatriated to the United States from Wuhan, China, and the Diamond Princess cruise ship were excluded.
Kiisas dadka kamidka ah kuwa dib loogu soo celiyay Maraykanka ee laga keenay Wuhan, Shiinaha, iyo markabka dalxiiska Diamond Cruise ayaa laga saaray.
For cases with missing onset dates, date of onset was estimated by subtracting 4 days (median interval from symptom onset to specimen collection date among cases with known dates in these data) from the earliest specimen collection.
Kiisaska aan lahayn taariikh ay bilawdeen, taariikhda bilawga waxaa lagu qiyaasay in 4 maalin laga jaro (u dhaxayn dhexdhexaad ah laga soo bilaabo calaamadu markay ku bilaabatay ilaa taariikhda soo qaadida tiaabada oo ay kamid yihiin kiisaska leh taariikh la yaqaano ee xogtan) tijaabo soo qaadidii ugu horaysay.
Public health departments reported cases to CDC using a standardized case report form that captures information (yes, no, or unknown) on the following conditions and potential risk factors: chronic lung disease (inclusive of asthma, chronic obstructive pulmonary disease [COPD], and emphysema); diabetes mellitus; cardiovascular disease; chronic renal disease; chronic liver disease; immunocompromised condition; neurologic disorder, neurodevelopmental, or intellectual disability; pregnancy; current smoking status; former smoking status; or other chronic disease.
Waaxyaha caafimaadka bulshada waxay u soo sheegeen CDC iyagoo isticmaalaya foom kiis soo sheegid oo casriyaysan kaas oo leh macluumaadka (haa, maya, mise lama yaqaan) xaalada soo socda iyo khatar caabuq oo suurtagaal ah: sanbab xanuun daba dheeraday (oo ay ku jiraan neef qabadka, , sanbabo xanuun (COPD), iyo emphysema); sonkorawga mellirus; wadna xanuun; kalyo xanuun; beer xanuun; xaalad difaac yari; isdaba mar neerfo, neerfo koritaan la'aan, naafo dhanka maanka ah; uur; xaalada sigaar cabida ee hadda; xaalada sigaar cabida ee hore; misane xanuun kale oo daba dheeraaday.
Data reported to CDC are preliminary and can be updated by health departments over time; critical data elements might be missing at the time of initial report; thus, this analysis is descriptive, and no statistical comparisons could be made.
Macluumaadka laga soo sheegay CDC waa kuwa hordhac ah waxaana la ogaysiin karaa waaxda caafimaadka waqti kadib, qaybo macluumaadka ah oo muhiim ah ayaa laga yaabaa in ay maqanyihiin markii la samaynayay waribixinta hore, sidaas awgeed, taxliilinta sharaxaadaha garaaf ahaaneed, iyo isbarbardhigyada istaatistik ahaaneed waa in la sameeyaa.
The percentages of patients of all ages with underlying health conditions who were not hospitalized, hospitalized without ICU admission, and hospitalized with ICU admission were calculated.
Boqollayda bukaanada ee dhamaan da'a kasta ee kujira xaaladaha caafimaad ee hooseeya, kuwa la daaweeyay ayaga oo aan lagalinin qaybta daryeelka dagdaga ah, iyo kuwa la daaweeyay lana galiyay qaybta daryeelka dagdaga ah ayaa la xisaabiyay.
Percentages of hospitalizations with and without ICU admission were estimated for persons aged ≥19 years with and without underlying health conditions.
Boqolayda dadka la daaweeyay ee la galiyay ama aan la galinin qaybta daryeelka dagdaga ah ayaa lagu qiyaasay in dad ay da'doodo tahay mid ≥19 sanno oo isugu jiro kuwa kujira xaalado caafimaad ee hooseeyaiyo kuwaa aan ku jirin ba.
This part of the analysis was limited to persons aged ≥19 years because of the small sample size of cases in children with reported underlying health conditions (N = 32).
Taxliilinta qaybtan waxay ku koobneyd uu dadka da'doodu tahay ≥19 sanno sababtoo ah yaraanta tirada sanbalka ee kiisaska caruurta ee lagu soo waramay in ku jiraan xaaladaha caafimaad ee hooseeya (N = 32).
To account for missing data among these preliminary reports, ranges were estimated with a lower bound including cases with both known and unknown status for hospitalization with and without ICU admission as the denominator and an upper bound using only cases with known outcome status as the denominator.
Si loo xisaabiyo macluumaadka maqan ee warbixinta hordhaca ah, farqiga ayaa lagu qiyaasay xad hoose oo ay ku jiraan kiisaska leh kuwa la ogyahay iyo kuwa aan la ogayn ba ee xaalada daweeyn ahaaneed ee leh kuwa la galiyay iyo kuwa aan lagalinin qaybta daryeelka dagdaha labadaba sababto ah lambarka hooseeyaha ah iyo xadka kore waxay isticmaalayaan kaliya lambarka hooseeyaha kiisaska la aqoonsaday heerka natiijada.
Because of small sample size and missing data on underlying health conditions among COVID-19 patients who died, case-fatality rates for persons with and without underlying conditions were not estimated.
Sababtoo ah yaraanta tirada sanbalka iyo la'aanta macluumaadka bukaanada COVID-19 ee galay xaaladaha caafimaad ee hooseeya ee dhintay, heerka kiiska dhimashada ee dadka leh ama aan lahayn xaalado caafimaad ee dagdag ah ayaan la qiyaasin.
As of March 28, 2020, a total of 122,653 laboratory-confirmed COVID-19 cases (Figure) and 2,112 deaths were reported to CDC.
Ilaa MAarso 28, 2020, wadarta guud ee kiisaska shaybaar ee COVID-19 ee la xaqiijiyay ayaa ah 122,653 (Jaantuus) iyo 2,112 dhimasho ayaa lasoo wargaliyay CDC.
Case report forms were submitted to CDC for 74,439 (60.7%) cases.
Foormamka wargalinta kiis ayaa loo gudbiyay CDC iyadoo ah 74,439 (60.7%) kiisas.
Data on presence or absence of underlying health conditions and other recognized risk factors for severe outcomes from respiratory infections (i.e., smoking and pregnancy) were available for 7,162 (5.8%) patients (Table 1).
macluumaadka haynta ama hayn la'aanta dadka kujira xaaladaha caafimaad ee hooseeya, ama aqoosashada asbaabo kale oo halis ah ee natiijooyin ba'an ee caabuqa neef-mareenka (sida sigaar cabida iyo uurka) ayaa laga heli karaa bukaanda 7,162 (5.8%) (Jaantuuska 1).
Approximately one third of these patients (2,692, 37.6%), had at least one underlying condition or risk factor.
Qiyaas ahaan, saddex meelood hal meel oo bukaanadan ah (2,692, 37.6%) waxay ugu yaraan lahaayeen xaalad ama sabab halis ah.
Diabetes mellitus (784, 10.9%), chronic lung disease (656, 9.2%), and cardiovascular disease (647, 9.0%) were the most frequently reported conditions among all cases.
Sokorow (784, 10.9%), xanuunada sambabaha ee daba dheeraada (656, 9.2%), iyo cudurada wadna xanuunka (647, 9.0%) ayaa ah xaaladaha sida joogtada ah loo soo sheego dhamaan kiisaska.
Among 457 ICU admissions and 1,037 non-ICU hospitalizations, 358 (78%) and 732 (71%), respectively occurred among persons with one or more reported underlying health condition.
457ka ka mid ah kuwa lagaliyay qabta daryeelka dagdaga ah ICU iyo 1,037 aan lagu daaweyn qaybta daryeelka dagdaga ah, 358 (78%) iyo 732 (71%), sida ay isugu xigaan ah ayaa noqday hal ama kabadan ee lagu soo waramay e qaba xaaladaha caafimaad ee hooseeya.
In contrast, 1,388 of 5,143 (27%) COVID-19 patients who were not hospitalized were reported to have at least one underlying health condition.
Taas badalkeed, 1,88 oo ka mid ah 5,143 (27%) bukaanada COVID-19 kuwaas oo aan la daaweyn ayaa lagu soo waramay in ay qabaan ugu yaraan hal xaalad caafimaadeed oo hoosaysa.
Among patients aged ≥19 years, the percentage of non-ICU hospitalizations was higher among those with underlying health conditions (27.3%–29.8%) than among those without underlying health conditions (7.2%–7.8%); the percentage of cases that resulted in an ICU admission was also higher for those with underlying health conditions (13.3%–14.5%) than those without these conditions (2.2%–2.4%) (Table 2).
qayb ka mid ah bukaanada qaar da'dooda tahay ≥19 sanno, boqolayda dadka aan lagu daaweynta qaybta daryeelka dagdaga ah ayaa ka sareeyay kuwa qaba xaaladaha caafimaad ee hooseeya (27.3%-29.8%) marka loo eego kuwa qaba xaaladaha caafimaad ee hooseeya (7.2%-7.8%); boqolayda kiisaska la galiyay qaybta daryeelka dagdaga ah ayaa sdioo kale ka koreysa kuwa qaba xaaladaha caafimaad ee hooseeya (13.3%-14.5%) marka loo eego kuwa aan qabin xaaladaha caafimaad ee hooseeya (2.2%-2.4%0 (Jadwalka 2).
Small numbers of COVID-19 patients aged &lt; 19 years were reported to be hospitalized (48) or admitted to an ICU (eight).
Tiro yara oo bukaano ah oo da'dooda tahay < 19 sanno ayaa lagu wargaliyay in la daweeyay (48) ama la galiyay qaybta daryeelka dagdaga ah ICU (sideed).
In contrast, 335 patients aged &lt; 19 years were not hospitalized and 1,342 had missing data on hospitalization.
Taas badalkeed, 335 bukaan oo da'dooda tahay < 19 sanno ayaan la daaweynin 1,342 waaxaa maqan xogtooda daaweyneed.
Among all COVID-19 patients with complete information on underlying conditions or risk factors, 184 deaths occurred (all among patients aged ≥19 years); 173 deaths (94%) were reported among patients with at least one underlying condition.
Qayb ka mid ah dhamaan bukaanada COVID-19 kuwaas oo leh macluumaad dhamaystiran oo xalaad hoose ama asbaaba khatar ah,184 dhimasho ayaa dhacay (dhamaan bukaanada da'dooda waxay eheed ≥19 sanno); 173 dhimasho (94%) ayaa lagu soo waramay bukaanada qaba ugu yaraan hal xaalad oo hooseysa.
Among 122,653 U.S. COVID-19 cases reported to CDC as of March 28, 2020, 7,162 (5.8%) patients had data available pertaining to underlying health conditions or potential risk factors; among these patients, higher percentages of patients with underlying conditions were admitted to the hospital and to an ICU than patients without reported underlying conditions.
Qayb ka mid 122,653 kiis oo bukaanada Maraykanka ah ayaa lagu wargaliyay CDC ilaa Maarso 28, 2020, 7,162 (5.8%) bukaanada ah waxay lahaayeen xaalado la xariira caafimaad oo hooseeya ama suurta galnimada asbaabaha khatar ah; tiro badan oo ka mid ah bukaanada qaba xaaladaha caafimaad ee hoose waxaa la dhigay isbitaal waxaana laga qaybta daryeelka dagdaga ah marka loo eego bukaanada aan qabin xaalad caafimaad oo hooseysa.
These results are consistent with findings from China and Italy, which suggest that patients with underlying health conditions and risk factors, including, but not limited to, diabetes mellitus, hypertension, COPD, coronary artery disease, cerebrovascular disease, chronic renal disease, and smoking, might be at higher risk for severe disease or death from COVID-19.
Natiijooyinkan waa kuwa isba joog ah oo leh natiijooyin laga keenay Shiinaha iyo Talyaaniga, kuwaas oo soo jeedinaya in bukaanada qaba xaalada caafimaad ee hooseeya ama asbaaba khatar ah, oo ay ku jiraan, balse aan ku koobnayn, sokorow, dhiig kar, cudurada xidida dhiiga siiya wadnaha, xanuunada maskaxda ku dhaca, xanuunada kalyaha oo daba-dheeraday, iyo sigaar cabida, aya laga yaaba in halis aas usare ugu jiraan xanuunka halista ama udhimashada COVID-19.
This analysis was limited by small numbers and missing data because of the burden placed on reporting health departments with rapidly rising case counts, and these findings might change as additional data become available.
Taxliilintan waxay ku koobnayd tiro yar iyo xog maqan sababtoo ah culayska la saaray ee wargalinta waaxda caafimaadka taas oo leh kor u kicitaan xawli ah ee tirada guud ee kiisaska, natiijooyinka waxaa laga yaabaa in ay isbadalaan hadii macluumaad dheeri ah la helo.
It is not yet known whether the severity or level of control of underlying health conditions affects the risk for severe disease associated with COVID-19.
Wali lama oga in halista ama heerka xakamaynta xaaladaha caafimaad ee hooseeya in ay saamayso iyo in kale xanuunka halista ah ee la xiriira COVID-19.
Many of these underlying health conditions are common in the United States: based on self-reported 2018 data, the prevalence of diagnosed diabetes among U.S. adults was 10.1%, and the U.S. age-adjusted prevalence of all types of heart disease (excluding hypertension without other heart disease) was 10.6% in 2017.
Inta badan xaaladaha caafimaad ee hooseeya waxay ku badanyihiin Maraykanka: iyadoo lagu salaynayo xogta wargalinta shakhsi ahaaneed 2018, baahsanaanta baadhitaanada sokorowga ee dadka waaweyn ee Maraykanka waa 10.1%, baahsanaanta dhamaan noocyada cudurada wadna xanuun ee da'a kasta (laga saarayo dhiig karka oo aan la jirin wadna xanuun kale) wuxuu ahaa 10.6% sanadkii 2017 ka.
The age-adjusted prevalence of COPD among U.S. adults is 5.9%, and in 2018, the U.S. estimated prevalence of current asthma among persons of all ages was 7.9%.
Baahsanaanta da''da ee COPD ee dadka waaweyn ee Maraykan waa 5.9%, 2018 dhediisa Maraykanka wuxuu ku qiyaasay baahsanaanta xiiqda ee hadda ee dadka da'aha oo dhan in ay ahayd 7.9%
CDC continues to develop and update resources for persons with underlying health conditions to reduce the risk of acquiring COVID-19.
CDC waxay sii wadaa in ay hormarto oo ay cusboonaysiiso khayraadkeeda ee dadka qaba xaaladaha caafimaad ee hooseeya si ay u dhinto khatarta laga helayo COVID-19.
The estimated higher prevalence of these conditions among those in this early group of U.S. COVID-19 patients and the potentially higher risk for more severe disease from COVID-19 associated with the presence of underlying conditions highlight the importance of COVID-19 prevention in persons with underlying conditions.
Baahsanaanta sare ee la qiyaasay ee xalaadahan oo ay ku jiraan kooxaha hore ee bukaanada COVID-19 ee Maraykanka iyo suurtagalnimada khatarta sare ee xanuuno badan oo halis oo ka yimaada COVID-19 ee la xiriira jiritaanka xaaladaha hoose sheeg muhiimada ka hortaga COVID-19 ee dadka qaba xaaladaha hoose.
The findings in this report are subject to at least six limitations.
Natiijooyinka warbixintan waxay u nugul yihiin lix dhibaato.
First, these data are preliminary, and the analysis was limited by missing data related to the health department reporting burden associated with rapidly rising case counts and delays in completion of information requiring medical chart review; these findings might change as additional data become available.
Ugu horeyn, macluumadan waa hordhac, taxliilintuna way xadidnaydmadaama xogta qaaar aan la haynin oo la xariira culayska wargalinta waaxda caafimaadka ee la halmaala kor ukaca tirada guud ee hawliga iyo dib u dhigadhamaystir macluumaadkan oo u baahan dib u eegida jaantuuska caafimaad; natiijooyinka waxaa lagaa yabaa in ay isbadalaan hadii macluumaad heeri ah la helo.
Information on underlying conditions was only available for 7,162 (5.8%) of 122,653 cases reported to CDC.
Macluumadka xaaladaha hoose ee la helay waa kaliya 7,162 (5.8%) oo ka mid ah 122,653 kiis oo lagu wargaliyay CDC.
It cannot be assumed that those with missing information are similar to those with data on either hospitalizations or underlying health conditions.
Looma qaadan in macluumaadka maqan ay la mid yihiin xogta lahayo ee daaweyn ahaaneed ama xalaado caafimaad oo hoose mid uun.
Second, these data are subject to bias in outcome ascertainment because of short follow-up time.
Marka labaad, xogtan waxay u nugushahay kala eexsho hubinta natiijo ahaaneed sababtoo ah qwaqtiga daba-galka oo yar.
Some outcomes might be underestimated, and long-term outcomes cannot be assessed in this analysis.
Natiijooyinka qaar ayaa laga yaaba in qiyaas ahaan hoos loo dhigo, iyo natiijooyinka muddada-dheerna luguma qiimeyn karo taxliilintan.
Third, because of the limited availability of testing in many jurisdictions during this period, this analysis is likely biased toward more severe cases, and findings might change as testing becomes more widespread.
Saddexaad, sababtoo ah helitaanka xadidan ee baadhitaanada ee maxkamadaynaha inta lagu jiro, taxliilintan waxay u eegtahay mid eexasho leh marka la eego kiisas badan oo halis ah. natiijooyinkana waxaa laga yaabaa in ay isbadallaan marka baadhitaanku la faafiyo.
Fourth, because of the descriptive nature of these data, attack rates among persons with and without underlying health conditions could not be compared, and thus the risk difference of severe disease with COVID-19 between these groups could not be estimated.
Afraad, sababtoo dabiicada falanqaynta garaaf ahaaneed ee xogtan, heerka weerarka ee dadka qabama ama aan qabin xaaladaha caafimaad ee hooseeya la isma barbar dhigi karo, sidaas awgeed kala duwanaanshaha halista xanuunka COVID-19 ee kooxahan lama qiyaasi karo.
Fifth, no conclusions could be drawn about underlying conditions that were not included in the case report form or about different conditions that were reported in a single, umbrella category.
Shanaad, ma jiraan wax goaano kama dambays ah oo laga soo saaray xalaadaha caafimaad ee hooseeya kuwaas oo aan lagu darin foomka wargalinta kiiska ama kala duwanaanshaha xaaladaha lasoo sheegay hal mar, hal dalad.
For example, asthma and COPD were included in a chronic lung disease category.
Tusaale ahaan, Xiiqda iyo COPD ayaa lagu daray qaybaha xanuunada sambabka ee halista ah.
Finally, for some underlying health conditions and risk factors, including neurologic disorders, chronic liver disease, being a current smoker, and pregnancy, few severe outcomes were reported; therefore, conclusions cannot be drawn about the risk for severe COVID-19 among persons in these groups.
Ugu dambeyn, qaar xaaladaha caafimaadkee hooseeya iyo asbaabaha khatarta,oo ay ku jiraan ciladaha shaqada neerfaha, xanuunka ba'an ee beerka, ahaansha qof sigaar caba isla waqtigaas, iyo uurka, natiijoyin yar oo halis ah ayaa laga soo sheegay; sidaas awgeed, goaanada kama dambaysta ah lagama soo saari karo halista na'an ee COVID-19 ee dadka kooxahaas ka midka ah.
Persons in the United States with underlying health conditions appear to be at higher risk for more severe COVID-19, consistent with findings from other countries.
Dadka joogta Maraykan ee qaba xalaadaha caafimaad ee hooseeya waxay u muuqdaan in ay halis weyn ugu jiraan COVID-19 ka halista ah, marka loo eego natiijooyinka wadanada kale.
Persons with underlying health conditions who have symptoms of COVID-19, including fever, cough, or shortness of breath, should immediately contact their health care provider.
Dadka qaba xaaladaha caafimaad ee hooseeya ee leh calaamadaha COVID-19, oo ay ku jiraan qandho, qufac, ama neefsasho yaraan, waa in ay si dagdag ah ula xiriiraan bixiyayaashooda daryeelka caafimaad.
These persons should take steps to protect themselves from COVID-19, through washing their hands; cleaning and disinfecting high-touch surfaces; and social distancing, including staying at home, avoiding crowds, gatherings, and travel, and avoiding contact with persons who are ill.
Daddka qaata talaabooyinka ay naftooda kaga ilaalinayaan COVID-19, ayagoo dhaqaya gacmohooda; nadiifinaya oo ku nadiifinaya goobaha sida aadka ah loo taabto jeermis dilaha; iyo kala fogaanshaha bulshadeed, oo ay ku jiraan in guriga la joogo, ka fogaansha isu imaanshaha dad badan, kulamada, iyo safarada, iyo ka fogaanshaha taabshada qof qaba xanuunka.
Maintaining at least a 30-day supply of medication, a 2-week supply of food and other necessities, and knowledge of COVID-19 symptoms are recommended for those with underlying health conditions.
Joogtaynta ugu yaraan 30 oo daawa qaybin ah, 2-isbuuc oo cunto qaybin ah iyo waxyaalaha kale aasaasiga ah, iyo aqoonsashada calaamadaha COVID-19 ayaa loo soo jeediyay dadka qaba xalaadaha caafimaad ee hooseeya.
All persons should take steps to protect themselves from COVID-19 and to protect others.
Dhamaan dadka waa in ay qaataan talaabooyinka ay iskaga ilaalinayaan COVID-19 ayna kaga ilaalinayaan dadka kale.
All persons who are ill should stay home, except to get medical care; should not go to work; and should stay away from others.
Dhamaan dadka xanuunsan waa in ay guryaha joogaan, marka laga reebo in ay doonanayaan daryeel caafimaad, waa in aysan shaqa aadin, dadka kale na way in ka fogaadaan.
This is especially important for those who work with persons with underlying conditions or who otherwise are at high risk for severe outcomes from COVID-19.
Tani waxay gaar ahaan muhiimad u tahay dadka la shaqeeya dad qaba xaalada hooseeya ama kuwa sidoo kale halis sare ugu jira natiijooyin xun ee COVID-19.
Community mitigation strategies, which aim to slow the spread of COVID-19, are important to protect all persons from COVID-19, especially persons with underlying health conditions and other persons at risk for severe COVID-19–associated disease (https://www.cdc.gov/coronavirus/2019-ncov/downloads/community-mitigation-strategy.pdf).
Istaraatijiyadaha hoos u dhiga ee bulshada, taas oo ujeedkeedu yahay hoos u dhigida faafitaanka COVID-19, in ay yihiin kuwa muhiim ah si looga ilaaliyo dhamaan dadka COVID-19, gaar ahaan dadka qaba xaaladaha caafimaad ee hooseeya iyo dadka kale halista ugu jira xanuunada ba'an ee la xiriira COVID-19 (https://www.cdc.gov/coronavirus/2019-ncov/downloads/community-mitigation-strategy.pdf).
What is already known about this topic?
Ilaa hadda maxaa laga ogyahay mawduucan?
Published reports from China and Italy suggest that risk factors for severe COVID-19 disease include underlying health conditions, but data describing underlying health conditions among U.S. COVID-19 patients have not yet been reported.
Warbino lagu daabacay Shiinaha iyo Talyaaniga waxay soo jeedinayaan in asbaabaha halista ee xanuun ba'an ee COVID-19ay ku jiraan xaaladaha caafimaad ee hooseeya, lakiin macluumaadka waxay qeexayaan bukaanada qaba xaaladaha caafimaad ee hoseeeya ee ka midka ah buukanada COVID-19 ee Maraykanka in aan wali lasoo wargalin.
What is added by this report?
Warbixintan maxay ku dartay?